Type 1 diabetes: treatment [sounds like]
362 results
101 - 200Dry eye syndrome
Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
Insulin therapy in type 2 diabetes
Eye symptoms and signs of systemic diseases
Exercise and diet for preventing type 2 diabetes mellitus
Hypoglycaemia in a patient with diabetes
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus
Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2
Home glucose monitoring offers no benefit to patients not using insulin
GLP-1 analogues for weight loss among patients with type 2 diabetes
Guidelines for when to consider mortality-reducing treatments for patients with type 2 diabetes
Enhanced glucose control for preventing and treating diabetic neuropathy in type 1 diabetes
Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
Incidental glucosuria in children
Comprehensive treatment and follow-up of type 2 diabetes
Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
J-shaped survival curve for glycemic control in patients with type 2 DM
Follow-up of type 1 diabetes
Interventions for people with type 2 diabetes mellitus fasting during Ramadan
AHA/ACC guideline for the primary prevention of stroke
Fenofibrate for diabetic retinopathy
Treatment of periodontitis for glycaemic control in people with diabetes mellitus
Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
Intensive control of blood sugar (HbA1c < 7.0%) in DM2 may be harmful (ACCORD)
Glucose targets for preventing diabetic kidney disease and its progression
Metabolic syndrome
Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
Diet and exercise counseling does not reduce cardiovascular or all-cause mortality associated with prediabetes and type 2 diabetes
Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
Severe hypoglycemic episodes raise risk of dementia in adults with T2DM
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Dietary advice and exercise for type 2 diabetes mellitus
Reducing cardiovascular events by multifactorial intervention in patients with type 2 diabetes
SGLT-2 inhibitors in type 2 diabetes
Insulin added on metformin in type 2 diabetes
Blood pressure control for diabetic retinopathy
Altered dietary salt intake for preventing diabetic kidney disease and its progression
Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
USPSTF 2017 does not recommend for or against screening for celiac disease in asymptomatic patients (I statement)
Gestational diabetes mellitus (GDM)
Self-monitoring ineffective in patients with diabetes (ESMON)
Peroxisome proliferator‐activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
Proteinuria
NICE guidelines for diabetes mellitus, type 2
Risk of severe hypoglycemia similar between different insulin formulations
Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
Diabetic kidney disease (diabetic nephropathy)
ADA/EASD updated guidelines: glycemic control is only part of the management of type 2 diabetes
Group based training for self-management strategies in people with type 2 diabetes mellitus
Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia
Sulphonylurea for type 2 diabetes
Alpha‐lipoic acid for diabetic peripheral neuropathy
Air travel and illness
Fenofibrate decreases amputation in patients with type 2 DM (FIELD)
(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
Metformin should be initial therapy for adults with type 2 DM
Association of glycaemic control and complications of type 2 diabetes
Glycaemic control for slowing the progression of microvascular complications in diabetes mellitus
Prevention of type 2 diabetes in persons at increased risk for the development of T2D
Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
Hypothyroidism in children
Lifestyle interventions for the treatment of women with gestational diabetes
GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease
Ayurvedic treatments for diabetes mellitus: Cochrane systematic review
Intensive versus conventional glycaemic control for treating diabetic foot ulcers
Prevention of type 2 diabetes by life-style changes
Gestational diabetes mellitus and future risk of diabetes
Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
Unintentional weight loss in adults
Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes
Oral antidiabetic drugs and GLP-1 analogues
Continuous glucose monitoring systems for type 1 diabetes mellitus
Scoliosis and kyphosis
Intensive glucose control ineffective in ICU patients
Relaxed hemoglobin A1c goals for T2DM from the American College of Physicians
Diabetic ketoacidosis
Different lasers and techniques for proliferative diabetic retinopathy: Cochrane systematic review
Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings
Newer hypoglycemics don't increase or decrease mortality
High-dose B-vitamins harmful to patients with diabetic nephropathy
Oral anti‐diabetic pharmacological therapies for the treatment of women with gestational diabetes
SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
Gout and pseudogout